Quicklinks by Audience
Our Mission
To ease the burden of cancer in our catchment area in North Texas through exceptional patient care, transdisciplinary research, discovery, community engagement and education, partnership, and collaboration.
Transdisciplinary Research
UT Southwestern physicians and scientists conduct laboratory research, clinical research, and population-based research, leading to new drugs and treatments - with the sole purpose of improving patient care and ultimately saving lives.
Promotes research to increase understanding of molecular mechanisms altered in tumor cells and their microenvironment that support cancer initiation and metastatic progression.
More Info Cellular Networks in Cancer
Focuses on the discovery of drug-like chemicals that affect biological processes causal to the development and progression of cancer.
More Info Chemistry and Cancer
Brings together investigators in developmental and cancer stem cell biology to discover how aberrant developmental processes contribute to initiation and progression of cancer.
More Info Development and Cancer
Promotes, develops, and exploits mechanism-based research for improved therapy of human cancer.
More Info Experimental Therapeutics
Focuses on cross-cutting themes of cancer health disparities and health services research in the catchment’s safety-net systems, recognizing Dallas’s great socioeconomic and ethnic diversity.
More Info Population Science and Cancer
Key Facts
UT Southwestern provides over a dozen major cancer care programs that advance the treatment and prevention of cancer through innovative therapies, leading-edge clinical trials and the latest technology.
227
Members
34
Departments
582
2019 Member Publications
$25M
NCI Direct Cost Funding
$71M
Peer-Reviewed Direct Cost Funding
$85M
Overall Direct Cost Extramural Cancer Funding
1,400
2019 Interventional Clinical Trial Accrual
1,930
2019 Interventional and Non-Interventional Clinical Trial Accrual
441
Active Clinical Trials
Collaborative Teams of Experts
Simmons Cancer Center supports 13 multidisciplinary teams of individual clinicians and researchers woven together to bring broad expertise to bear on scientific and clinical challenges unique to different cancers. These experts facilitate access to compassionate, quality, leading-edge care including the forefront of what's available in Clinical Trials.
State-of-the-Art Research & Clinical Facilities
Why NCI?
- The top cancer specialists in the country
- Cutting-edge therapies
- Seamless disease-oriented teams collaborating for each patient
- A broad array of treatment options
- Leading-edge clinical trials
- The most advanced technology and equipment
- State-of-the-art clinics and hospitals
National Comprehensive Cancer Network
As a NCCN Member Institution, Simmons integrates multidisciplinary teams to provide high-quality patient care, research, and education.
Message from the Director
World renowned breast cancer specialist and investigator
Associate Dean of Oncology Programs
